Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -6.05% |
|
-4.00% | -21.43% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
Financials (USD)
Sales 2024 * | 74.39M | Sales 2025 * | 28.75M | Capitalization | 256M |
---|---|---|---|---|---|
Net income 2024 * | -152M | Net income 2025 * | -226M | EV / Sales 2024 * | 3.44 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.9 x |
P/E ratio 2024 * |
-1.83
x | P/E ratio 2025 * |
-1.47
x | Employees | 335 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.34% |
1 day | -6.05% | ||
1 week | -4.00% | ||
Current month | -11.71% | ||
1 month | -17.24% | ||
3 months | -13.73% | ||
6 months | -22.12% | ||
Current year | -21.43% |
![Extreme 2.635](/images/extremecours_fleche.png)
![Extreme 2.6](/images/extremecours_fleche.png)
![Extreme 1.87](/images/extremecours_fleche.png)
![Extreme 1.54](/images/extremecours_fleche.png)
![Extreme 1.54](/images/extremecours_fleche.png)
![Extreme 1.54](/images/extremecours_fleche.png)
![Extreme 1.54](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 23-03-31 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 15-05-31 |
Mark Gergen
CHM | Chairman | 61 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 18-12-31 |
Cynthia Collins
BRD | Director/Board Member | 65 | 21-07-22 |
Mark Gergen
CHM | Chairman | 61 | 18-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.87% | 2 M€ | -25.75% | ||
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-18 | 2.64 | -6.05% | 240,522 |
24-06-17 | 2.81 | +1.81% | 201,496 |
24-06-14 | 2.76 | -3.16% | 98,022 |
24-06-13 | 2.85 | +1.79% | 101,012 |
24-06-12 | 2.8 | +1.82% | 298,529 |
Delayed Quote Nasdaq, June 18, 2024 at 04:00 pm EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.43% | 256M | |
+14.84% | 121B | |
+18.31% | 112B | |
+1.66% | 22.72B | |
-18.26% | 20.82B | |
-41.55% | 16.36B | |
-14.23% | 16.19B | |
-17.96% | 16.66B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- PSTX Stock